TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Infectious Vaccines Market Insights, Forecast to 2028

Global Infectious Vaccines Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 23 July 2022
  • Pages :113
  • Formats:
  • Report Code:SMR-7227884
OfferClick for best price

Best Price: $3920

Infectious Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Infectious Vaccines Market

The global Infectious Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Vaccines market.

Global Infectious Vaccines Scope and Market Size

Infectious Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Infectious Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Preventive Vaccine

Therapeutic Vaccine

Segment by Application

Adults

Pediatrics

By Company

CSL Limited (Australia)

Bavarian Nordic (Denmark)

GlaxoSmithKline plc. (U.K.)

Emergent Bio Solutions Inc. (U.S.)

MedImmune LLC (U.S.)

Johnson and Johnson (U.S.)

Novartis AG (Switzerland)

Merck and Company (U.S.)

Sanofi Pasteur (France)

Pfizer Inc. (U.S.)

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Infectious Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Infectious Vaccines, with price, sales, revenue, and global market share of Infectious Vaccines from 2019 to 2022.

Chapter 3, the Infectious Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Infectious Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Infectious Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Vaccines.

Chapter 13, 14, and 15, to describe Infectious Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Infectious Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Infectious Vaccines Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 113 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 Market by Application
1.3.1 Global Infectious Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Pediatrics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Infectious Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Infectious Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infectious Vaccines Sales by Region
2.4.1 Global Infectious Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Infectious Vaccines by Region (2023-2028)
2.5 Global Infectious Vaccines Revenue by Region
2.5.1 Global Infectious Vaccines Revenue by Region (2017-2022)
2.5.2 Global Infectious Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infectious Vaccines Sales by Manufacturers
3.1.1 Global Top Infectious Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Infectious Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Vaccines in 2021
3.2 Global Infectious Vaccines Revenue by Manufacturers
3.2.1 Global Infectious Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Infectious Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2021
3.3 Global Infectious Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infectious Vaccines Sales by Type
4.1.1 Global Infectious Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Infectious Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Infectious Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Infectious Vaccines Revenue by Type
4.2.1 Global Infectious Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Infectious Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infectious Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Infectious Vaccines Price by Type
4.3.1 Global Infectious Vaccines Price by Type (2017-2022)
4.3.2 Global Infectious Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infectious Vaccines Sales by Application
5.1.1 Global Infectious Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Infectious Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Infectious Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Infectious Vaccines Revenue by Application
5.2.1 Global Infectious Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Infectious Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infectious Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Infectious Vaccines Price by Application
5.3.1 Global Infectious Vaccines Price by Application (2017-2022)
5.3.2 Global Infectious Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infectious Vaccines Market Size by Type
6.1.1 North America Infectious Vaccines Sales by Type (2017-2028)
6.1.2 North America Infectious Vaccines Revenue by Type (2017-2028)
6.2 North America Infectious Vaccines Market Size by Application
6.2.1 North America Infectious Vaccines Sales by Application (2017-2028)
6.2.2 North America Infectious Vaccines Revenue by Application (2017-2028)
6.3 North America Infectious Vaccines Market Size by Country
6.3.1 North America Infectious Vaccines Sales by Country (2017-2028)
6.3.2 North America Infectious Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Infectious Vaccines Market Size by Type
7.1.1 Europe Infectious Vaccines Sales by Type (2017-2028)
7.1.2 Europe Infectious Vaccines Revenue by Type (2017-2028)
7.2 Europe Infectious Vaccines Market Size by Application
7.2.1 Europe Infectious Vaccines Sales by Application (2017-2028)
7.2.2 Europe Infectious Vaccines Revenue by Application (2017-2028)
7.3 Europe Infectious Vaccines Market Size by Country
7.3.1 Europe Infectious Vaccines Sales by Country (2017-2028)
7.3.2 Europe Infectious Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infectious Vaccines Market Size by Type
8.1.1 Asia Pacific Infectious Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Infectious Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Infectious Vaccines Market Size by Application
8.2.1 Asia Pacific Infectious Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Infectious Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Infectious Vaccines Market Size by Region
8.3.1 Asia Pacific Infectious Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Infectious Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Infectious Vaccines Market Size by Type
9.1.1 Latin America Infectious Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Infectious Vaccines Revenue by Type (2017-2028)
9.2 Latin America Infectious Vaccines Market Size by Application
9.2.1 Latin America Infectious Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Infectious Vaccines Revenue by Application (2017-2028)
9.3 Latin America Infectious Vaccines Market Size by Country
9.3.1 Latin America Infectious Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Infectious Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Infectious Vaccines Market Size by Type
10.1.1 Middle East and Africa Infectious Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infectious Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Infectious Vaccines Market Size by Application
10.2.1 Middle East and Africa Infectious Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infectious Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Infectious Vaccines Market Size by Country
10.3.1 Middle East and Africa Infectious Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infectious Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Limited (Australia)
11.1.1 CSL Limited (Australia) Corporation Information
11.1.2 CSL Limited (Australia) Overview
11.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Limited (Australia) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Limited (Australia) Recent Developments
11.2 Bavarian Nordic (Denmark)
11.2.1 Bavarian Nordic (Denmark) Corporation Information
11.2.2 Bavarian Nordic (Denmark) Overview
11.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bavarian Nordic (Denmark) Recent Developments
11.3 GlaxoSmithKline plc. (U.K.)
11.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
11.3.2 GlaxoSmithKline plc. (U.K.) Overview
11.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline plc. (U.K.) Recent Developments
11.4 Emergent Bio Solutions Inc. (U.S.)
11.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
11.4.2 Emergent Bio Solutions Inc. (U.S.) Overview
11.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments
11.5 MedImmune LLC (U.S.)
11.5.1 MedImmune LLC (U.S.) Corporation Information
11.5.2 MedImmune LLC (U.S.) Overview
11.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 MedImmune LLC (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 MedImmune LLC (U.S.) Recent Developments
11.6 Johnson and Johnson (U.S.)
11.6.1 Johnson and Johnson (U.S.) Corporation Information
11.6.2 Johnson and Johnson (U.S.) Overview
11.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson and Johnson (U.S.) Recent Developments
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Corporation Information
11.7.2 Novartis AG (Switzerland) Overview
11.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Novartis AG (Switzerland) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG (Switzerland) Recent Developments
11.8 Merck and Company (U.S.)
11.8.1 Merck and Company (U.S.) Corporation Information
11.8.2 Merck and Company (U.S.) Overview
11.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck and Company (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck and Company (U.S.) Recent Developments
11.9 Sanofi Pasteur (France)
11.9.1 Sanofi Pasteur (France) Corporation Information
11.9.2 Sanofi Pasteur (France) Overview
11.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Pasteur (France) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Pasteur (France) Recent Developments
11.10 Pfizer Inc. (U.S.)
11.10.1 Pfizer Inc. (U.S.) Corporation Information
11.10.2 Pfizer Inc. (U.S.) Overview
11.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infectious Vaccines Industry Chain Analysis
12.2 Infectious Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Vaccines Production Mode & Process
12.4 Infectious Vaccines Sales and Marketing
12.4.1 Infectious Vaccines Sales Channels
12.4.2 Infectious Vaccines Distributors
12.5 Infectious Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Vaccines Industry Trends
13.2 Infectious Vaccines Market Drivers
13.3 Infectious Vaccines Market Challenges
13.4 Infectious Vaccines Market Restraints
14 Key Findings in The Global Infectious Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Infectious Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Preventive Vaccine
Table 3. Major Manufacturers of Therapeutic Vaccine
Table 4. Global Infectious Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Infectious Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Infectious Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Infectious Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Infectious Vaccines Sales by Region (2023-2028) & (K Units)
Table 9. Global Infectious Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Infectious Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Infectious Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Infectious Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Infectious Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Infectious Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Infectious Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Infectious Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Infectious Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Infectious Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Infectious Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2021)
Table 21. Infectious Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Infectious Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Infectious Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 26. Global Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 27. Global Infectious Vaccines Sales Share by Type (2017-2022)
Table 28. Global Infectious Vaccines Sales Share by Type (2023-2028)
Table 29. Global Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Infectious Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Infectious Vaccines Revenue Share by Type (2023-2028)
Table 33. Infectious Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Infectious Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 36. Global Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 37. Global Infectious Vaccines Sales Share by Application (2017-2022)
Table 38. Global Infectious Vaccines Sales Share by Application (2023-2028)
Table 39. Global Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Infectious Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Infectious Vaccines Revenue Share by Application (2023-2028)
Table 43. Infectious Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Infectious Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 46. North America Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 47. North America Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 50. North America Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 51. North America Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 54. North America Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 55. North America Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 58. Europe Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 59. Europe Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 62. Europe Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 63. Europe Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 66. Europe Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 67. Europe Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Infectious Vaccines Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Infectious Vaccines Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Infectious Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Infectious Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Infectious Vaccines Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Infectious Vaccines Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Infectious Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Infectious Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Infectious Vaccines Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Infectious Vaccines Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Infectious Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Infectious Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Infectious Vaccines Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Infectious Vaccines Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Infectious Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Infectious Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. CSL Limited (Australia) Corporation Information
Table 106. CSL Limited (Australia) Description and Major Businesses
Table 107. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. CSL Limited (Australia) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. CSL Limited (Australia) Recent Developments
Table 110. Bavarian Nordic (Denmark) Corporation Information
Table 111. Bavarian Nordic (Denmark) Description and Major Businesses
Table 112. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bavarian Nordic (Denmark) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bavarian Nordic (Denmark) Recent Developments
Table 115. GlaxoSmithKline plc. (U.K.) Corporation Information
Table 116. GlaxoSmithKline plc. (U.K.) Description and Major Businesses
Table 117. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GlaxoSmithKline plc. (U.K.) Recent Developments
Table 120. Emergent Bio Solutions Inc. (U.S.) Corporation Information
Table 121. Emergent Bio Solutions Inc. (U.S.) Description and Major Businesses
Table 122. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Emergent Bio Solutions Inc. (U.S.) Recent Developments
Table 125. MedImmune LLC (U.S.) Corporation Information
Table 126. MedImmune LLC (U.S.) Description and Major Businesses
Table 127. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. MedImmune LLC (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. MedImmune LLC (U.S.) Recent Developments
Table 130. Johnson and Johnson (U.S.) Corporation Information
Table 131. Johnson and Johnson (U.S.) Description and Major Businesses
Table 132. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Johnson and Johnson (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Johnson and Johnson (U.S.) Recent Developments
Table 135. Novartis AG (Switzerland) Corporation Information
Table 136. Novartis AG (Switzerland) Description and Major Businesses
Table 137. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Novartis AG (Switzerland) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Novartis AG (Switzerland) Recent Developments
Table 140. Merck and Company (U.S.) Corporation Information
Table 141. Merck and Company (U.S.) Description and Major Businesses
Table 142. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Merck and Company (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck and Company (U.S.) Recent Developments
Table 145. Sanofi Pasteur (France) Corporation Information
Table 146. Sanofi Pasteur (France) Description and Major Businesses
Table 147. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Sanofi Pasteur (France) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sanofi Pasteur (France) Recent Developments
Table 150. Pfizer Inc. (U.S.) Corporation Information
Table 151. Pfizer Inc. (U.S.) Description and Major Businesses
Table 152. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Pfizer Inc. (U.S.) Infectious Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Pfizer Inc. (U.S.) Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Infectious Vaccines Distributors List
Table 158. Infectious Vaccines Customers List
Table 159. Infectious Vaccines Market Trends
Table 160. Infectious Vaccines Market Drivers
Table 161. Infectious Vaccines Market Challenges
Table 162. Infectious Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Vaccines Product Picture
Figure 3. Global Infectious Vaccines Market Share by Type in 2021 & 2028
Figure 3. Preventive Vaccine Product Picture
Figure 4. Therapeutic Vaccine Product Picture
Figure 5. Global Infectious Vaccines Market Share by Application in 2021 & 2028
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Infectious Vaccines Report Years Considered
Figure 9. Global Infectious Vaccines Sales 2017-2028 (K Units)
Figure 10. Global Infectious Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Infectious Vaccines Revenue 2017-2028 (US$ Million)
Figure 12. Global Infectious Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Infectious Vaccines Sales Market Share by Region (2017-2022)
Figure 14. Global Infectious Vaccines Sales Market Share by Region (2023-2028)
Figure 15. North America Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 16. North America Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Infectious Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Infectious Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Infectious Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Infectious Vaccines in the World: Market Share by Infectious Vaccines Revenue in 2021
Figure 27. Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 29. Global Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 30. Global Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 31. Global Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 32. North America Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. North America Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 35. North America Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. North America Infectious Vaccines Sales Share by Country (2017-2028)
Figure 37. North America Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 38. U.S. Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 41. Europe Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 42. Europe Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 43. Europe Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 44. Europe Infectious Vaccines Sales Share by Country (2017-2028)
Figure 45. Europe Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 46. Germany Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 47. France Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Infectious Vaccines Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Infectious Vaccines Revenue Share by Region (2017-2028)
Figure 57. China Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. India Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Latin America Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Latin America Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Infectious Vaccines Sales Share by Country (2017-2028)
Figure 72. Latin America Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 73. Mexico Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Infectious Vaccines Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Infectious Vaccines Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Infectious Vaccines Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Infectious Vaccines Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Infectious Vaccines Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Infectious Vaccines Revenue Share by Country (2017-2028)
Figure 82. Turkey Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Infectious Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Infectious Vaccines Value Chain
Figure 86. Infectious Vaccines Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount